{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:43:52Z","timestamp":1786725832532,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate factors associated with the occurrence of ROCM in COVID-19 patients and to compare its related parameters and outcomes between active and recovered COVID-19 groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 35 patients of ROCM associated with COVID-19 (active and post-COVID-19) were included. This is an ambispective study with retrospective medical records review for COVID-19 analysis and prospective assessments of ROCM-associated COVID-19 during the second wave of the COVID-19 pandemic. The demographic data, clinical parameters, and outcome were recorded on MS excel sheet, and various parameters were compared between active and recovered COVID-19 groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      ROCM in recovered COVID-19 group was higher (57.1%) as compared to active COVID-19 (42.9%) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 1.00). High occurrence of ROCM was seen in those who had a history of hospitalization due to severity of COVID-19 (n 33, 94.28%), oxygen support (77.14), and received systemic steroids (82.9%). The most common comorbidity was diabetes mellitus (82.9%), and new-onset hyperglycemia was noticed in 17.1% of patients. Exenteration (28.6%) was performed in severe cases who had stage IV ROCM, bilateral, and CNS involvement (RR = 7.2, 95% CI: 2.91 to 18.00). The risk of globe exenteration was 1.35 (0.7-2.29) times higher in recovered COVID-19 group, and mortality was 1.76 (0.72-3.36) times higher in active COVID-19 group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Monitored use of systemic steroids and the prompt management of hyperglycemia in COVID-19 patients are important factors for favorable outcomes with reference to globe salvage and life-saving in ROCM associated with COVID-19. Even recovered COVID-19 patients should be observed for persistent hyperglycemia and occurrence of ROCM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_356_23","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:47Z","timestamp":1700438447000},"page":"3669-3676","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Study of rhino-orbital-cerebral mucormycosis and its correlates during COVID-19 pandemic in a tertiary eye care institute of central India"],"prefix":"10.4103","volume":"71","author":[{"given":"Vidhya","family":"Verma","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepayan","family":"Sarkar","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruttendu","family":"Moharana","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Noyadu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"R1-20260511","article-title":"IndiaFightsCorona COVID-19","year":"2020","journal-title":"MyGov.in"},{"key":"R2-20260511","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R3-20260511","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed"},{"key":"R4-20260511","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/jof5030059","article-title":"Mucormycosis of the Central Nervous System","volume":"5","author":"Chikley","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"R5-20260511","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.2337\/dc21-1318","article-title":"COVID-19, hyperglycemia, and new-onset diabetes","volume":"44","author":"Khunti","year":"2021","journal-title":"Diabetes Care"},{"key":"R6-20260511","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4103\/ijo.IJO_310_21","article-title":"Rise of the phoenix: Mucormycosis in COVID-19 times","volume":"69","author":"Ravani","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R7-20260511","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R8-20260511","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","article-title":"Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R9-20260511","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/28.suppl_A.13","article-title":"The clinical presentation and diagnosis of invasive fungal infections","volume":"28","author":"Maartens","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"R10-20260511","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: A review of cases from 18 countries","volume":"3","author":"Hoenigl","year":"2022","journal-title":"Lancet Microbe"},{"key":"R11-20260511","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4103\/ijo.IJO_1165_21","article-title":"Code Mucor: Guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19","volume":"69","author":"Honavar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R12-20260511","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO study on mucormycosis in COVID-19 (COSMIC), report 1","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R13-20260511","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/myc.13334","article-title":"Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran","volume":"64","author":"Pakdel","year":"2021","journal-title":"Mycoses"},{"key":"R14-20260511","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.2147\/OPTH.S324977","article-title":"Rhino-orbito-cerebral-mucormycosis during the COVID-19 second wave in 2021 \u2013 A preliminary report from a single hospital","volume":"15","author":"Arora","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"R15-20260511","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0039-6257(05)80041-4","article-title":"Survival factors in rhino-orbital-cerebral mucormycosis: Major review","volume":"39","author":"Yohai","year":"1994","journal-title":"Surv Ophthalmol"},{"key":"R16-20260511","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12070-007-0034-1","article-title":"Rhinocerebral mucormycosis: A deadly disease on the rise","volume":"59","author":"Mane","year":"2007","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"R17-20260511","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.virol.2013.06.026","article-title":"Glycolytic control of vacuolar-type ATPase activity: A mechanism to regulate influenza viral infection","volume":"444","author":"Kohio Hinissan","year":"2013","journal-title":"Virology"},{"key":"R18-20260511","doi-asserted-by":"crossref","first-page":"15","DOI":"10.18869\/acadpub.cmm.2.4.15","article-title":"Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral Mucormycosis - A retrospective analysis","volume":"2","author":"Abdollahi","year":"2016","journal-title":"Curr Med Mycol"},{"key":"R19-20260511","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/myc.12474","article-title":"Mucormycosis in Iran: A systematic review","volume":"59","author":"Vaezi","year":"2016","journal-title":"Mycoses"},{"key":"R20-20260511","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/mmy\/myy060","article-title":"A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment","volume":"57","author":"Prakash","year":"2019","journal-title":"Med Mycol"},{"key":"R21-20260511","doi-asserted-by":"crossref","first-page":"108118","DOI":"10.1016\/j.diabres.2020.108118","article-title":"Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed","volume":"162","author":"Wang","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"R22-20260511","doi-asserted-by":"crossref","first-page":"e000775","DOI":"10.1136\/bmjophth-2021-000775","article-title":"Ocular manifestations of RT-PCR-confirmed COVID-19 cases in a large database cross-sectional study","volume":"6","author":"Sarkar","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"key":"R23-20260511","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1038\/s41467-021-23886-3","article-title":"Viral infiltration of pancreatic islets in patients with COVID-19","volume":"12","author":"Steenblock","year":"2021","journal-title":"Nat Commun"},{"key":"R24-20260511","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, uncontrolled diabetes and corticosteroids\u2014An unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis","volume":"20","author":"Moorthy","year":"2021","journal-title":"J Maxillofac Oral Surg"},{"key":"R25-20260511","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"R26-20260511","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: A deadly addition to the pandemic spectrum","volume":"135","author":"Sharma","year":"2021","journal-title":"J Laryngol Otol"},{"key":"R27-20260511","first-page":"2","article-title":"Spike in rhino-orbital-cerebral mucormycosis cases presenting to a tertiary care center during the COVID-19 pandemic","volume":"40","author":"Fouad","year":"2021","journal-title":"Front Med"},{"key":"R28-20260511","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0161-6420(83)80052-9","article-title":"Diagnosis and management of rhino-orbitocerebral mucormycosis (phycomycosis): A report of 16 personally observed cases","volume":"90","author":"Ferry","year":"1983","journal-title":"Ophthalmology"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_356_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:26:19Z","timestamp":1786724779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_356_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_356_23","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"assertion":[{"value":"2023-02-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}